LISATA THERAPEUTICS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
LISATA THERAPEUTICS, INC. (LSTA) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2018-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2018-03-31 was $0.00.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2018 was $0.00.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2017 was -$638.00K, a 114.00% decline from fiscal 2016.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2016 was $4.56M.
- LISATA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2014 was $0.00.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $69.00 derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $69.00 derived: sum of 3 quarters · filed 2019-03-14 | $69.00 derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $69.00 derived: sum of 2 quarters · filed 2019-03-14 | $69.00 derived: sum of 3 quarters · filed 2019-03-14 | $4.86M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-12-31 | $69.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $69.00 derived: sum of 2 quarters · filed 2019-03-14 | $4.86M derived: sum of 3 quarters · filed 2019-03-14 | -$638.00K 10-K · filed 2019-03-14 | -$638.07K 10-K · filed 2018-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.86M derived: sum of 2 quarters · filed 2018-11-08 | -$638.07K 10-Q · filed 2018-11-08 | $1.31M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$638.07K 10-Q · filed 2018-08-09 | $1.31M derived: sum of 3 quarters · filed 2018-08-09 | $1.32M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$5.49M 10-Q · filed 2018-05-10 | -$3.55M derived: sum of 2 quarters · filed 2018-05-10 | -$3.54M derived: sum of 3 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $1.96M derived: sum of 2 quarters · filed 2018-03-22 | $4.56M 10-K · filed 2018-03-22 | ||
| 2016-09-30 | $5.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.61M 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $2.60M 10-Q · filed 2017-08-10 | ||||
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $0.00 10-K · filed 2015-03-02 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | -$7.26M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | -$7.26M derived: sum of 3 quarters · filed 2015-03-02 | -$4.08M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | -$7.26M derived: sum of 2 quarters · filed 2015-03-02 | -$4.08M derived: sum of 3 quarters · filed 2015-03-02 | -$814.29K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$4.08M derived: sum of 2 quarters · filed 2015-03-02 | -$814.29K derived: sum of 3 quarters · filed 2015-03-02 | $4.91M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.45M derived: sum of 2 quarters · filed 2013-11-07 | $12.17M 10-Q · filed 2013-11-07 | $14.58M derived: sum of 4 quarters · filed 2013-11-07 | |
| 2012-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $8.99M 10-Q · filed 2013-08-08 | $11.40M derived: sum of 3 quarters · filed 2013-08-08 | $13.97M derived: sum of 4 quarters · filed 2013-08-08 | |
| 2012-03-31 | $5.72M 10-Q · filed 2013-05-09 | $8.13M derived: sum of 2 quarters · filed 2013-05-09 | $10.70M derived: sum of 3 quarters · filed 2013-05-09 | ||
| 2011-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $4.98M derived: sum of 2 quarters · filed 2013-03-11 | $845.21K 10-K · filed 2013-03-11 | ||
| 2011-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$1.56M 10-Q · filed 2012-11-13 | |||
| 2011-06-30 | -$4.14M 10-Q · filed 2012-08-14 | ||||
| 2010-12-31 | $10.20M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |